TY - JOUR
T1 - Drug transport proteins in the liver
AU - Faber, Klaas Nico
AU - Muller, M.
AU - Jansen, P.LM
N1 - Review 4
PY - 2003/1/21
Y1 - 2003/1/21
N2 - Together with drug metabolising enzymes, transmembrane transporters are important determinants of drug metabolism and drug clearance by the liver. Hepatic uptake of organic anions, cations, prostaglandins and bile salts is supported by dedicated transporter proteins in the basolateral (sinusoidal) membrane of hepatocytes: OATPs, OATs, OCTs, PGTs and NTCP, respectively. ATP-binding cassette (ABC) transporter proteins in the canalicular membrane of hepatocytes mediate the hepatic efflux of drugs, bile salts and metabolites against a steep concentration gradient from liver to bile. This transport is driven by ATP hydrolysis. Drugs, endogenous metabolites, bile salts and cytokines affect the expression levels of these transporters. They act through a family of ligand-activated transcription factors, the nuclear hormone receptors. Consequently, the levels of the various transporter proteins are subject to genetic polymorphism in the encoding genes as well as in these transcription factors. Adverse drug reactions may be caused by genetic or disease-induced variations of transporter expression or drug-drug interactions at the level of these transporters. (C) 2002 Elsevier Science B.V. All rights reserved.
AB - Together with drug metabolising enzymes, transmembrane transporters are important determinants of drug metabolism and drug clearance by the liver. Hepatic uptake of organic anions, cations, prostaglandins and bile salts is supported by dedicated transporter proteins in the basolateral (sinusoidal) membrane of hepatocytes: OATPs, OATs, OCTs, PGTs and NTCP, respectively. ATP-binding cassette (ABC) transporter proteins in the canalicular membrane of hepatocytes mediate the hepatic efflux of drugs, bile salts and metabolites against a steep concentration gradient from liver to bile. This transport is driven by ATP hydrolysis. Drugs, endogenous metabolites, bile salts and cytokines affect the expression levels of these transporters. They act through a family of ligand-activated transcription factors, the nuclear hormone receptors. Consequently, the levels of the various transporter proteins are subject to genetic polymorphism in the encoding genes as well as in these transcription factors. Adverse drug reactions may be caused by genetic or disease-induced variations of transporter expression or drug-drug interactions at the level of these transporters. (C) 2002 Elsevier Science B.V. All rights reserved.
KW - solute carriers
KW - ATP-binding cassette transporters
KW - organic anion transporting proteins
KW - organic cation transporting protein
KW - prostaglandin transporter
KW - drug efflux pumps
KW - P-glycoproteins
KW - multidrug resistance proteins
KW - nuclear hormone receptors
KW - ORGANIC ANION TRANSPORTER
KW - SALT EXPORT PUMP
KW - RESISTANCE-ASSOCIATED PROTEIN-3
KW - HEPATOCYTE NUCLEAR FACTOR-1-ALPHA
KW - P-GLYCOPROTEIN EXPRESSION
KW - PLASMA-MEMBRANE VESICLES
KW - ATP-DEPENDENT TRANSPORT
KW - S-CONJUGATE TRANSPORT
KW - B OATP-B
KW - RAT-LIVER
M3 - Article
SN - 0169-409X
VL - 55
SP - 107
EP - 124
JO - Advanced Drug Delivery Reviews
JF - Advanced Drug Delivery Reviews
IS - 1
M1 - PII S0169-409X(02)00173-4
ER -